SCHEMBL9022876

SCHEMBL9022876

COc1ccc(-c2nc(-c3ccccc3)cc(C(C)C)c2/C=C/[C@@H]2C[C@@H](O)CC(=O)O2)cc1

nearest known ligand 0.81

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 9/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10424677 0.91 HMGCR (0.85) HMGCR
SCHEMBL9022338 0.90 HMGCR (1.00) HMGCR
SCHEMBL9528573 0.90 HMGCR (1.00) HMGCR
SCHEMBL10424679 0.88 HMGCR (0.63) HMGCR
SCHEMBL10424088 0.83 HMGCR (0.87) HMGCR
SCHEMBL9022250 0.83 HMGCR (0.86) HMGCR
SCHEMBL9022891 0.81 HMGCR (0.84) HMGCR
SCHEMBL10424009 0.81 HMGCR (0.83) HMGCR
SCHEMBL10425480 0.79 HMGCR (0.88) HMGCR
SCHEMBL10425482 0.79 HMGCR (0.59) HMGCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0307342-B1 3-Demethyl-4-fluoro-mevalonic-acid derivatives, process for their preparation, pharmaceutical preparations based on those compounds, their use and intermediates HOECHST AG (DE) 1996-01-03 EP disclosed
US-4925852-A TREATMENT OR PROPHYLAXIS OF ARTERIOSCLEROSIS OR HYPERCHOLESTEROLEMIA HOECHST AKTIENGESELLSCHAFT (DE) 1990-05-15 US disclosed